The U.S. Food and Drug Administration today approved Verzenio (abemaciclib) to treat adult patients who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer that has ...
Protecting The Heart During Cancer Treatment
Dr. Agnes Kim, director of the cardio-oncology program at UConn Health, uses a new echocardiography strain imaging to detect signs of potential heart problems in cancer patients, before clinical symptoms are evident. (Tina Encarnacion | UCONN HEALTH).
No comments:
Post a Comment